Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Lynn Payer
John Wiley & Sons, $12.95, pp 292
ISBN 0 471 00737 4
This title is now only available direct from the USA. See www.wiley.com






Rating: 


Lynn Payer's Disease-Mongers is passionate,
provocative, and prescient. The book's thesis is simple, compelling,
and for many people utterly counter-intuitive: doctors, drug companies,
and device manufacturers are engaged in "broadening the definitions of diseases" in order to increase demand for their products and services. Since the book was first published in 1992, the evidence has
mounted that Payer's disturbing view of the medical establishment is
all too accurate.
Payer quickly establishes her argument that the boundaries of disease
are fluid, and that there are too many vested interests trying to push
those boundaries as wide as possible. In tough, accessible prose she
details the way that doctors, drug companies, test makers, medical
writers, hospitals, courts, and insurance companies are all caught up
in a frenzy of disease-mongering: "Trying to convince essentially
well people that they are sick, or slightly sick people that they are
very ill Payer also explores the many tactics of the disease-mongers,
including turning normal life into a disease (for example, menopause), exaggerating the suffering attached to mild problems (for example, premenstrual syndrome), and using extreme, unrepresentative examples of
severe symptoms when depicting a common condition (for example, bone-thinning). Payer's criticisms of the media are particularly biting, arguing that it often forms part of an "unholy alliance" with industry and the medical profession, to make a condition look as
widespread and serious as possible.
But the book is in fact much bigger than a critique of
disease-mongering. It also introduces a lay audience to the move to an
evidence based approach in medicine, and ends with constructive suggestions for reshaping the US healthcare system.
Disease-Mongers is not a well known book, partly because of
its own flaws. Although Payer synthesises highly complex scientific evidence and makes it comprehensible to a wide lay audience, she has
not crafted a racy non-fiction narrative.
The best things about this book are its three central claims To write the book off as gratuitously anti-doctor or anti-drug would be
a gross error. The great power of Payer's thesis is this: resources
wasted on expensive and needless tests or therapies for the healthy are
resources that could have been available to ameliorate or prevent the
suffering of the genuinely ill. Yes, deciding where to draw the line
between what is healthy and what is legitimately treatable pathology is
not always easy. But as Payer has helped us to understand, to continue
to allow those with vested interests to have such a strong influence
over those decisions is plainly unhealthy.
is big business."
which are
illustrated by plenty of examples, and backed by good evidence from the
world's leading medical journals. Firstly, more and more of the
processes and ailments of life are being seen as medical problems.
Second, self interested forces seek to make those medical conditions
look as widespread and serious as possible. Thirdly, the therapies for
these problems are oversold: their benefits are played up, their harms
are played down.
Ray Moynihan ray_128{at}hotmail.com
What can you learn from this BMJ paper? Read Leanne Tite's Paper+